Archean Chemical Industries Ltd
Archean Chemical Industries Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Bromine production is expected to grow by 15%-20% annually, aiming to increase from ~20,000 tons to 25,000 tons next year, and eventually to 40,000 tons over time. Company aims for volume growth in core bromine and salt businesses, targeting 15%-20% annual bromine production growth, moving from ~20,000 tons to 25,000 tons next year and planning eventual capacity up to 40,000 tons.
From Archean Chemical Industries Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Bromine production is expected to grow by 15%-20% annually, aiming to increase from ~20,000 tons to 25,000 tons next year, and eventually to 40,000 tons over time.
- Industrial Salt business is anticipated to grow at 10%-12% annually, supported by brine field expansion enhancing both salt and liquor production for bromine.
- Bromine derivatives business is scaling up, with volume sales and revenue sharply increasing; focus on product development and capacity utilization improvements.
- SOP business is undergoing reengineering and is expected to scale up production from the second half of the year.
- Overall, the company is targeting volume growth across all core businesses through market penetration, product development, and long-term customer partnerships.
- Revenue growth is moderate due to pricing pressures but expected to improve with stabilization of costs and logistics, aiming at historical margin levels.
Profitability & Margins
See what Archean Chemical Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company is investing in strategic long-term opportunities in advanced materials, specifically in batteries and semiconductors.
- A pilot line for wafer manufacturing is under development at IIT Bhubaneshwar through SiCSem, with ongoing capital expenditure under intellectual property development and technology transfer agreements.
- A new area for expanding the brine pond has been established to enhance bromine production capacity, aiming for increased peak production around FY27 or FY28.
- Investments are focused on scaling up derivatives, oilfield, and SOP businesses alongside consolidating core salt and bromine businesses.
- Capital discipline is emphasized, with a focus on investing in projects with good returns and scaling existing businesses efficiently.
- No specific capex amount or timeline disclosed, but planned semiconductor plant production is expected 24-30 months from July of the current year.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Archean Chemical Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Archean Chemical Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹301 Cr, net profit ₹12 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Archean Chemical's management said in earlier quarters
- Q1 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q2 FY26 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
Others in Chemicals & Petrochemicals this season
- NOCIL (Q4 FY26)
The Rs.130 crores capex includes some intermediates and is largely for captive consumption, with part allocated to finished goods. Key concall takeaways from…
- Indo Borax & Ch. (Q4 FY26)
175 crores revenue in the previous financial year and Rs. Key concall takeaways from Indo Borax & Chemicals Ltd's Q4 FY26 earnings call — and how it ranks…
- Rossari Biotech Ltd (Q4 FY26)
50-70 crore planned for FY27 focused on pharma and aroma chemical facilities to support value-added product segments. Key concall takeaways from Rossari…
- Pidilite Inds. (Q4 FY26)
Underlying volume growth (UVG) averaged over 9% per quarter last year, with a ~200 bps increase in FY '25; the company plans to continue lifting UVG…
Frequently Asked Questions
What were Archean Chemical Industries Ltd Q4 FY26 results?
Bromine production is expected to grow by 15%-20% annually, aiming to increase from ~20,000 tons to 25,000 tons next year, and eventually to 40,000 tons over time. Company aims for volume growth in core bromine and salt businesses, targeting 15%-20% annual bromine production growth, moving from ~20,000 tons to 25,000 tons next year and planning eventual capacity up to 40,000 tons.
What is Archean Chemical Industries Ltd share price analysis?
Archean Chemical Industries Ltd currently shows a neutral. The stock trades at a P/E of 66.8 with a market cap of ₹6,467 Cr. Investors should review the full earnings analysis for detailed insights.
Is Archean Chemical Industries Ltd planning capital expenditure?
The company is investing in strategic long-term opportunities in advanced materials, specifically in batteries and semiconductors.
Keep Archean Chemical Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.